InvestorsHub on MSN
Klotho Neurosciences advances epigenetic diagnostics with development of AI-driven "Klotho Clock"
Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...
SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a “lightning talk” as part of the “Understanding Pre-cancers ...
Bruker now extends their complete biology approach to mouse research by announcing development of the CosMx Mouse Whole Transcriptome (WTX) assay. The mouse WTX assay will be available for both FFPE ...
The primary causes of disability and mortality in the US are chronic diseases such as cancer, neurodegenerative disorders, cardiovascular disease, obesity, arthritis, and diabetes. The increase in ...
Professor of Chemical and Biological Engineering, Biomedical Engineering, and Public Health, Colorado State University A vast number of chemicals are registered for production and use around the world ...
A new collaboration enables rapid 1536-well assay development using Design of Experiments and automation. The approach ...
PEGASUS™ is an industry-first in peptide design: It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. Surrogate assays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results